EDWARDS LIFESCIENCES CORP (EW)
NYSE • Healthcare
Last close at July 2, 2026 at 20:00 UTC
Fundamentals Charts
About EDWARDS LIFESCIENCES CORP
Edwards Lifesciences Corporation (NYSE: EW) develops medical technology for structural heart disease, critical care, and surgical patient monitoring. The company sells to healthcare providers across the United States, Europe, Japan, and other international markets, and generated $6.1 billion of revenue in FY2025.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
EDWARDS LIFESCIENCES CORP's Technical Indicators Summary
EW presents a mixed picture with strong price placement above its short-, medium- and long-term moving averages, yet overbought oscillators and a tepid ADX signal a lack of clear trend momentum. Momentum and MACD show upside bias while RSI and Stochastics sit near overbought levels, and ATR indicates relatively contained volatility. OBV supports recent gains, and classic pivot price sits below the current level as short-term support. Technical takeaway: Neutral — price strength is evident on moving averages but oscillators and weak trend strength suggest consolidation risks.
| Indicator | Value |
|---|---|
RSI (14) | 70.09 |
Stochastic %K (14, 3, 3) | 88.34 |
CCI (20) | 170.53 |
WPR (14) | -0.88 |
Momentum (10) | 7.69 |
MFI | 68.56 |
MACD Level (12, 26) | 2.00 |
Bollinger Bands | $83.08 - $93.27 |
ATR (14) | $2.45 (2.60%) |
ADX (14) | 18.77 |
OBV | 72,860,424 |
Classic Pivot Point | $91.55 |
Fibonacci Pivot Point | $91.55 |
Exponential Moving Averages | $82.70 - $90.46(5 indicators) |
Simple Moving Averages | $82.45 - $89.84(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The day concluded with EW retaining the 2.60% gap it started with from yesterday. End-of-day, the peer group was firmly higher (2.65%), reinforcing a risk-on tone. EW held the prior gap as its medical devices peers rallied, supported by upbeat trial data and a new CFO.
Trading Volume
0
vs S&P 500 Today
Outperforming Market
+2.72%
52-Week Position
Near highs
99.6%
Updated: July 2, 2026 at 20:06 UTC